テロメラーゼ逆転写酵素の世界市場2020:メーカー別、地域別、種類・用途別

【英語タイトル】Global Telomerase Reverse Transcriptase Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20OC11324)・商品コード:GIR20OC11324
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年10月
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本書では、テロメラーゼ逆転写酵素の世界市場を調査対象にし、テロメラーゼ逆転写酵素の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ASTVAC-1、ASTVAC-2、ETS-2300、その他)、用途別分析(肺がん、卵巣がん、乳がん、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Argos Therapeutics Inc、Komipharm International Co Ltd、F. Hoffmann-La Roche Ltd、Asterias Biotherapeutics Inc、Johnson & Johnson、e-Therapeutics Plc、Telocyte LLC、Invectys SA、Inovio Pharmaceuticals Inc、Mediolanum farmaceutici SpA、TILT Biotherapeutics Ltd、Ultimovacs AS、Vaxon Biotech
・メーカー別販売量、売上、市場シェア
・テロメラーゼ逆転写酵素の地域別市場分析
・テロメラーゼ逆転写酵素の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・テロメラーゼ逆転写酵素のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・テロメラーゼ逆転写酵素のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・テロメラーゼ逆転写酵素の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・テロメラーゼ逆転写酵素の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・テロメラーゼ逆転写酵素の種類別市場規模2015-2020:ASTVAC-1、ASTVAC-2、ETS-2300、その他
・テロメラーゼ逆転写酵素の用途別市場規模2015-2020:肺がん、卵巣がん、乳がん、その他
・テロメラーゼ逆転写酵素の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The global Telomerase Reverse Transcriptase market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Telomerase Reverse Transcriptase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Telomerase Reverse Transcriptase market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Telomerase Reverse Transcriptase market has been segmented into
ASTVAC-1
ASTVAC-2
ETS-2300
Others

By Application, Telomerase Reverse Transcriptase has been segmented into:
Lung Cancer
Ovarian Cancer
Breast Cancer
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Telomerase Reverse Transcriptase market presented in the report. This section sheds light on the sales growth of different regional and country-level Telomerase Reverse Transcriptase markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Telomerase Reverse Transcriptase market.

The report offers in-depth assessment of the growth and other aspects of the Telomerase Reverse Transcriptase market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Telomerase Reverse Transcriptase Market Share Analysis
Telomerase Reverse Transcriptase competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Telomerase Reverse Transcriptase sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Telomerase Reverse Transcriptase sales, revenue and market share for each player covered in this report.

The major players covered in Telomerase Reverse Transcriptase are:
Argos Therapeutics Inc
Komipharm International Co Ltd
F. Hoffmann-La Roche Ltd
Asterias Biotherapeutics Inc
Johnson & Johnson
e-Therapeutics Plc
Telocyte LLC
Invectys SA
Inovio Pharmaceuticals Inc
Mediolanum farmaceutici SpA
TILT Biotherapeutics Ltd
Ultimovacs AS
Vaxon Biotech

Among other players domestic and global, Telomerase Reverse Transcriptase market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Telomerase Reverse Transcriptase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Telomerase Reverse Transcriptase, with price, sales, revenue and global market share of Telomerase Reverse Transcriptase in 2018 and 2019.
Chapter 3, the Telomerase Reverse Transcriptase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Telomerase Reverse Transcriptase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Telomerase Reverse Transcriptase market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Telomerase Reverse Transcriptase sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Telomerase Reverse Transcriptase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Telomerase Reverse Transcriptase Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ASTVAC-1
1.2.3 ASTVAC-2
1.2.4 ETS-2300
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Telomerase Reverse Transcriptase Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lung Cancer
1.3.3 Ovarian Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Overview of Global Telomerase Reverse Transcriptase Market
1.4.1 Global Telomerase Reverse Transcriptase Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Argos Therapeutics Inc
2.1.1 Argos Therapeutics Inc Details
2.1.2 Argos Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Argos Therapeutics Inc SWOT Analysis
2.1.4 Argos Therapeutics Inc Product and Services
2.1.5 Argos Therapeutics Inc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Komipharm International Co Ltd
2.2.1 Komipharm International Co Ltd Details
2.2.2 Komipharm International Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Komipharm International Co Ltd SWOT Analysis
2.2.4 Komipharm International Co Ltd Product and Services
2.2.5 Komipharm International Co Ltd Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche Ltd
2.3.1 F. Hoffmann-La Roche Ltd Details
2.3.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.3.4 F. Hoffmann-La Roche Ltd Product and Services
2.3.5 F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Asterias Biotherapeutics Inc
2.4.1 Asterias Biotherapeutics Inc Details
2.4.2 Asterias Biotherapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Asterias Biotherapeutics Inc SWOT Analysis
2.4.4 Asterias Biotherapeutics Inc Product and Services
2.4.5 Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 e-Therapeutics Plc
2.6.1 e-Therapeutics Plc Details
2.6.2 e-Therapeutics Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 e-Therapeutics Plc SWOT Analysis
2.6.4 e-Therapeutics Plc Product and Services
2.6.5 e-Therapeutics Plc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Telocyte LLC
2.7.1 Telocyte LLC Details
2.7.2 Telocyte LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Telocyte LLC SWOT Analysis
2.7.4 Telocyte LLC Product and Services
2.7.5 Telocyte LLC Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Invectys SA
2.8.1 Invectys SA Details
2.8.2 Invectys SA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Invectys SA SWOT Analysis
2.8.4 Invectys SA Product and Services
2.8.5 Invectys SA Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Inovio Pharmaceuticals Inc
2.9.1 Inovio Pharmaceuticals Inc Details
2.9.2 Inovio Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Inovio Pharmaceuticals Inc SWOT Analysis
2.9.4 Inovio Pharmaceuticals Inc Product and Services
2.9.5 Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mediolanum farmaceutici SpA
2.10.1 Mediolanum farmaceutici SpA Details
2.10.2 Mediolanum farmaceutici SpA Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mediolanum farmaceutici SpA SWOT Analysis
2.10.4 Mediolanum farmaceutici SpA Product and Services
2.10.5 Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 TILT Biotherapeutics Ltd
2.11.1 TILT Biotherapeutics Ltd Details
2.11.2 TILT Biotherapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 TILT Biotherapeutics Ltd SWOT Analysis
2.11.4 TILT Biotherapeutics Ltd Product and Services
2.11.5 TILT Biotherapeutics Ltd Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ultimovacs AS
2.12.1 Ultimovacs AS Details
2.12.2 Ultimovacs AS Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ultimovacs AS SWOT Analysis
2.12.4 Ultimovacs AS Product and Services
2.12.5 Ultimovacs AS Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Vaxon Biotech
2.13.1 Vaxon Biotech Details
2.13.2 Vaxon Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Vaxon Biotech SWOT Analysis
2.13.4 Vaxon Biotech Product and Services
2.13.5 Vaxon Biotech Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Telomerase Reverse Transcriptase Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Telomerase Reverse Transcriptase Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Telomerase Reverse Transcriptase Manufacturer Market Share in 2019
3.3.2 Top 6 Telomerase Reverse Transcriptase Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Telomerase Reverse Transcriptase Sales, Revenue and Market Share by Regions
4.1.1 Global Telomerase Reverse Transcriptase Sales and Market Share by Regions (2015-2020)
4.1.2 Global Telomerase Reverse Transcriptase Revenue and Market Share by Regions (2015-2020)
4.2 North America Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
4.3 Europe Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
4.5 South America Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Telomerase Reverse Transcriptase Sales, Revenue and Market Share by Country
5.1.1 North America Telomerase Reverse Transcriptase Sales and Market Share by Country (2015-2020)
5.1.2 North America Telomerase Reverse Transcriptase Revenue and Market Share by Country (2015-2020)
5.2 United States Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
5.3 Canada Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
5.4 Mexico Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Telomerase Reverse Transcriptase Sales, Revenue and Market Share by Country
6.1.1 Europe Telomerase Reverse Transcriptase Sales and Market Share by Country (2015-2020)
6.1.2 Europe Telomerase Reverse Transcriptase Revenue and Market Share by Country (2015-2020)
6.2 Germany Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
6.3 UK Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
6.4 France Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
6.5 Russia Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
6.6 Italy Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Telomerase Reverse Transcriptase Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Telomerase Reverse Transcriptase Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Telomerase Reverse Transcriptase Revenue and Market Share by Regions (2015-2020)
7.2 China Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
7.3 Japan Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
7.4 Korea Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
7.5 India Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
7.7 Australia Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Telomerase Reverse Transcriptase Sales, Revenue and Market Share by Country
8.1.1 South America Telomerase Reverse Transcriptase Sales and Market Share by Country (2015-2020)
8.1.2 South America Telomerase Reverse Transcriptase Revenue and Market Share by Country (2015-2020)
8.2 Brazil Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
8.3 Argentina Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Telomerase Reverse Transcriptase Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Telomerase Reverse Transcriptase Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Telomerase Reverse Transcriptase Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
9.3 Turkey Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
9.4 Egypt Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
9.5 South Africa Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Telomerase Reverse Transcriptase Sales and Market Share by Type (2015-2020)
10.2 Global Telomerase Reverse Transcriptase Revenue and Market Share by Type (2015-2020)
10.3 Global Telomerase Reverse Transcriptase Price by Type (2015-2020)
11 Global Telomerase Reverse Transcriptase Market Segment by Application
11.1 Global Telomerase Reverse Transcriptase Sales Market Share by Application (2015-2020)
11.2 Global Telomerase Reverse Transcriptase Revenue Market Share by Application (2015-2020)
11.3 Global Telomerase Reverse Transcriptase Price by Application (2015-2020)
12 Market Forecast
12.1 Global Telomerase Reverse Transcriptase Sales, Revenue and Growth Rate (2021-2025)
12.2 Telomerase Reverse Transcriptase Market Forecast by Regions (2021-2025)
12.2.1 North America Telomerase Reverse Transcriptase Market Forecast (2021-2025)
12.2.2 Europe Telomerase Reverse Transcriptase Market Forecast (2021-2025)
12.2.3 Asia-Pacific Telomerase Reverse Transcriptase Market Forecast (2021-2025)
12.2.4 South America Telomerase Reverse Transcriptase Market Forecast (2021-2025)
12.2.5 Middle East & Africa Telomerase Reverse Transcriptase Market Forecast (2021-2025)
12.3 Telomerase Reverse Transcriptase Market Forecast by Type (2021-2025)
12.3.1 Global Telomerase Reverse Transcriptase Sales Forecast by Type (2021-2025)
12.3.2 Global Telomerase Reverse Transcriptase Market Share Forecast by Type (2021-2025)
12.4 Telomerase Reverse Transcriptase Market Forecast by Application (2021-2025)
12.4.1 Global Telomerase Reverse Transcriptase Sales Forecast by Application (2021-2025)
12.4.2 Global Telomerase Reverse Transcriptase Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Telomerase Reverse Transcriptase Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Telomerase Reverse Transcriptase by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Telomerase Reverse Transcriptase Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Argos Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 8. Argos Therapeutics Inc Telomerase Reverse Transcriptase Major Business
Table 9. Argos Therapeutics Inc Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 10. Argos Therapeutics Inc SWOT Analysis
Table 11. Argos Therapeutics Inc Telomerase Reverse Transcriptase Product and Services
Table 12. Argos Therapeutics Inc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Komipharm International Co Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Komipharm International Co Ltd Telomerase Reverse Transcriptase Major Business
Table 15. Komipharm International Co Ltd Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 16. Komipharm International Co Ltd SWOT Analysis
Table 17. Komipharm International Co Ltd Telomerase Reverse Transcriptase Product and Services
Table 18. Komipharm International Co Ltd Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Major Business
Table 21. F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 22. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 23. F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Product and Services
Table 24. F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Asterias Biotherapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 26. Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Major Business
Table 27. Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 28. Asterias Biotherapeutics Inc SWOT Analysis
Table 29. Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Product and Services
Table 30. Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Telomerase Reverse Transcriptase Major Business
Table 33. Johnson & Johnson Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 34. Johnson & Johnson SWOT Analysis
Table 35. Johnson & Johnson Telomerase Reverse Transcriptase Product and Services
Table 36. Johnson & Johnson Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. e-Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 38. e-Therapeutics Plc Telomerase Reverse Transcriptase Major Business
Table 39. e-Therapeutics Plc Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 40. e-Therapeutics Plc SWOT Analysis
Table 41. e-Therapeutics Plc Telomerase Reverse Transcriptase Product and Services
Table 42. e-Therapeutics Plc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Telocyte LLC Basic Information, Manufacturing Base and Competitors
Table 44. Telocyte LLC Telomerase Reverse Transcriptase Major Business
Table 45. Telocyte LLC Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 46. Telocyte LLC SWOT Analysis
Table 47. Telocyte LLC Telomerase Reverse Transcriptase Product and Services
Table 48. Telocyte LLC Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Invectys SA Basic Information, Manufacturing Base and Competitors
Table 50. Invectys SA Telomerase Reverse Transcriptase Major Business
Table 51. Invectys SA Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 52. Invectys SA SWOT Analysis
Table 53. Invectys SA Telomerase Reverse Transcriptase Product and Services
Table 54. Invectys SA Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Inovio Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 56. Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Major Business
Table 57. Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 58. Inovio Pharmaceuticals Inc SWOT Analysis
Table 59. Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Product and Services
Table 60. Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Mediolanum farmaceutici SpA Basic Information, Manufacturing Base and Competitors
Table 62. Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Major Business
Table 63. Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 64. Mediolanum farmaceutici SpA SWOT Analysis
Table 65. Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Product and Services
Table 66. Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. TILT Biotherapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 68. TILT Biotherapeutics Ltd Telomerase Reverse Transcriptase Major Business
Table 69. TILT Biotherapeutics Ltd Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 70. TILT Biotherapeutics Ltd SWOT Analysis
Table 71. TILT Biotherapeutics Ltd Telomerase Reverse Transcriptase Product and Services
Table 72. TILT Biotherapeutics Ltd Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Ultimovacs AS Basic Information, Manufacturing Base and Competitors
Table 74. Ultimovacs AS Telomerase Reverse Transcriptase Major Business
Table 75. Ultimovacs AS Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 76. Ultimovacs AS SWOT Analysis
Table 77. Ultimovacs AS Telomerase Reverse Transcriptase Product and Services
Table 78. Ultimovacs AS Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Vaxon Biotech Basic Information, Manufacturing Base and Competitors
Table 80. Vaxon Biotech Telomerase Reverse Transcriptase Major Business
Table 81. Vaxon Biotech Telomerase Reverse Transcriptase Total Revenue (USD Million) (2018-2019)
Table 82. Vaxon Biotech SWOT Analysis
Table 83. Vaxon Biotech Telomerase Reverse Transcriptase Product and Services
Table 84. Vaxon Biotech Telomerase Reverse Transcriptase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Telomerase Reverse Transcriptase Sales by Manufacturer (2018-2019) (K Pcs)
Table 86. Global Telomerase Reverse Transcriptase Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Telomerase Reverse Transcriptase Sales by Regions (2015-2020) (K Pcs)
Table 88. Global Telomerase Reverse Transcriptase Sales Market Share by Regions (2015-2020)
Table 89. Global Telomerase Reverse Transcriptase Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Telomerase Reverse Transcriptase Sales by Countries (2015-2020) (K Pcs)
Table 91. North America Telomerase Reverse Transcriptase Sales Market Share by Countries (2015-2020)
Table 92. North America Telomerase Reverse Transcriptase Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Telomerase Reverse Transcriptase Revenue Market Share by Countries (2015-2020)
Table 94. Europe Telomerase Reverse Transcriptase Sales by Countries (2015-2020) (K Pcs)
Table 95. Europe Telomerase Reverse Transcriptase Sales Market Share by Countries (2015-2020)
Table 96. Europe Telomerase Reverse Transcriptase Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Telomerase Reverse Transcriptase Sales by Regions (2015-2020) (K Pcs)
Table 98. Asia-Pacific Telomerase Reverse Transcriptase Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Telomerase Reverse Transcriptase Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Telomerase Reverse Transcriptase Sales by Countries (2015-2020) (K Pcs)
Table 101. South America Telomerase Reverse Transcriptase Sales Market Share by Countries (2015-2020)
Table 102. South America Telomerase Reverse Transcriptase Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Telomerase Reverse Transcriptase Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Telomerase Reverse Transcriptase Sales by Countries (2015-2020) (K Pcs)
Table 105. Middle East & Africa Telomerase Reverse Transcriptase Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Telomerase Reverse Transcriptase Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Telomerase Reverse Transcriptase Revenue Market Share by Countries (2015-2020)
Table 108. Global Telomerase Reverse Transcriptase Sales by Type (2015-2020) (K Pcs)
Table 109. Global Telomerase Reverse Transcriptase Sales Share by Type (2015-2020)
Table 110. Global Telomerase Reverse Transcriptase Revenue by Type (2015-2020) (USD Million)
Table 111. Global Telomerase Reverse Transcriptase Revenue Share by Type (2015-2020)
Table 112. Global Telomerase Reverse Transcriptase Sales by Application (2015-2020) (K Pcs)
Table 113. Global Telomerase Reverse Transcriptase Sales Share by Application (2015-2020)
Table 114. Global Telomerase Reverse Transcriptase Sales Forecast by Regions (2021-2025) (K Pcs)
Table 115. Global Telomerase Reverse Transcriptase Market Share Forecast by Regions (2021-2025)
Table 116. Global Telomerase Reverse Transcriptase Sales Forecast by Type (2021-2025) (K Pcs)
Table 117. Global Telomerase Reverse Transcriptase Market Share Forecast by Type (2021-2025)
Table 118. Global Telomerase Reverse Transcriptase Sales Forecast by Application (2021-2025)
Table 119. Global Telomerase Reverse Transcriptase Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Telomerase Reverse Transcriptase Picture
Figure 2. Global Sales Market Share of Telomerase Reverse Transcriptase by Type in 2019
Figure 3. ASTVAC-1 Picture
Figure 4. ASTVAC-2 Picture
Figure 5. ETS-2300 Picture
Figure 6. Others Picture
Figure 7. Telomerase Reverse Transcriptase Sales Market Share by Application in 2018
Figure 8. Lung Cancer Picture
Figure 9. Ovarian Cancer Picture
Figure 10. Breast Cancer Picture
Figure 11. Others Picture
Figure 12. Global Telomerase Reverse Transcriptase Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Telomerase Reverse Transcriptase Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Telomerase Reverse Transcriptase Sales Market Share by Manufacturer in 2019
Figure 33. Global Telomerase Reverse Transcriptase Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Telomerase Reverse Transcriptase Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Telomerase Reverse Transcriptase Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Telomerase Reverse Transcriptase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Telomerase Reverse Transcriptase Revenue Market Share by Regions (2015-2020)
Figure 40. Global Telomerase Reverse Transcriptase Revenue Market Share by Regions in 2018
Figure 41. North America Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
Figure 42. Europe Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
Figure 44. South America Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020)
Figure 46. North America Telomerase Reverse Transcriptase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Telomerase Reverse Transcriptase Sales Market Share by Countries (2015-2020)
Figure 48. North America Telomerase Reverse Transcriptase Sales Market Share by Countries in 2018
Figure 49. North America Telomerase Reverse Transcriptase Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Telomerase Reverse Transcriptase Revenue Market Share by Countries in 2018
Figure 51. United States Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Telomerase Reverse Transcriptase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Telomerase Reverse Transcriptase Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Telomerase Reverse Transcriptase Revenue Market Share by Countries in 2019
Figure 57. Germany Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Telomerase Reverse Transcriptase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Telomerase Reverse Transcriptase Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Telomerase Reverse Transcriptase Revenue Market Share by Regions 2019
Figure 65. China Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Telomerase Reverse Transcriptase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Telomerase Reverse Transcriptase Sales Market Share by Countries in 2019
Figure 72. South America Telomerase Reverse Transcriptase Revenue Market Share by Countries in 2019
Figure 73. Brazil Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Telomerase Reverse Transcriptase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Telomerase Reverse Transcriptase Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Telomerase Reverse Transcriptase Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Telomerase Reverse Transcriptase Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Telomerase Reverse Transcriptase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Telomerase Reverse Transcriptase Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Telomerase Reverse Transcriptase Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Telomerase Reverse Transcriptase Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Telomerase Reverse Transcriptase Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Telomerase Reverse Transcriptase Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Telomerase Reverse Transcriptase Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Telomerase Reverse Transcriptase Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Argos Therapeutics Inc、Komipharm International Co Ltd、F. Hoffmann-La Roche Ltd、Asterias Biotherapeutics Inc、Johnson & Johnson、e-Therapeutics Plc、Telocyte LLC、Invectys SA、Inovio Pharmaceuticals Inc、Mediolanum farmaceutici SpA、TILT Biotherapeutics Ltd、Ultimovacs AS、Vaxon Biotech

★調査レポート[テロメラーゼ逆転写酵素の世界市場2020:メーカー別、地域別、種類・用途別] (コード:GIR20OC11324)販売に関する免責事項を必ずご確認ください。
★調査レポート[テロメラーゼ逆転写酵素の世界市場2020:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆